Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues SNY Q1 2026 Earnings EPS Surpasses Expectations Amidst Limited Revenue Disclosure ARQT Q1 2026 Earnings EPS Miss Amid Biotech Sector Headwinds CHDN Q1 2026 Earnings EPS Beats Estimates by 182 Stock Edges Lower GPCR Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as PreRevenue Biotech Advances Pipeline AGNCO Q1 2026 Earnings Strong EPS Surprise of 145 Drives Positive Stock Movement